Levels of DAP3 were low in breast cancer (18, 86) compared with the respective normal counterpart tissues and silencing of DAP3 promoted tumor progression, including enhanced adhesion, migration, and invasion in breast cancer cells (87), which indicated that increased expression of DAP3 was a favorable marker of prognosis in human breast cancer. Here, DAP3 is linked to breast carcinoma.